Results 121 to 130 of about 17,802 (177)

Severe hyponatremia masking cryptococcal meningitis in a fingolimod-treated patient: a case report. [PDF]

AME Case Rep
Nakahara S, Fujiuchi B, Nakata T, Majewski LL.   +3 more
europepmc   +1 more source

Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study. [PDF]

Mult Scler
Sandesjö F, McKay KA, Fink K, Piehl F, Wickström R.   +4 more
europepmc   +1 more source

Do apelin and ghrelin play a role in multiple sclerosis? The analysis of patients treated with immunomodulatory therapies. [PDF]

Front Immunol
Adamczyk B, Morawiec N, Rakoca M, Sowa A, Sawa K, Adamczyk-Sowa M.   +5 more
europepmc   +1 more source

Potential Role of Sphingosine-1-Phosphate and Its Receptors in the Reparative Processes of the Adult Brain. [PDF]

Int J Mol Sci
Gutner UA, Shupik MA, Alessenko A.
europepmc   +1 more source

Effects of Sphingosine 1-phosphate Modulators on Central Remyelination: A Systematic Review of Animal Models. [PDF]

Cell Mol Neurobiol
Vu H, George N, Xiao J.
europepmc   +1 more source

Higher disease reactivation risk in women after fingolimod withdrawal. [PDF]

Acta Neuropathol Commun
Massy M, Marti S, Kutllovci A, Frahm N, Fneish F, Ellenberger D, Hammer H, Chan A, Leichtle A, Lühder F, Metz I, Pistor M, Hoepner R.   +12 more
europepmc   +1 more source

LncRNA AFAP1-AS1 mediates therapy-dependent expression of CCL5, CXCL10 and MMP9 in multiple sclerosis. [PDF]

Biochem Biophys Rep
Hegazy LN, Elkhodiry AA, Rashad MH, Moustafa RR, El Tayebi HM.   +4 more
europepmc   +1 more source

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models. [PDF]

Oncol Res
Gousseau P, Genest L, Froget G, Rupp T.
europepmc   +1 more source

Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients. [PDF]

Front Neurol
Liu P, Liu W, Zhang X, Yuan P.
europepmc   +1 more source

Neuroprotective crosstalk from vitamin B12 and sphingolipid signaling pathways in therapy for multiple sclerosis. [PDF]

Int Immunol
Kihara Y, Chun J.
europepmc   +1 more source